Tuesday, November 24, 04:45 am IST
Hot Searches:  mukesh ambanisugarforbes rich list
| Feedback
Moneycontrol » News Center » Stocks » Expert Advic
Buy Ranbaxy on all declines: Gujral
Published on Mon, Jun 09, 2008 at 16:24   |  Updated at Mon, Jun 09, 2008 at 17:07  |  Source : CNBC-TV18

Technical Analyst, Ashwani Gujral is of the view that Ranbaxy Laboratories is doing very well. So, people can go long on that on all declines.

Gujral told CNBC-TV18, "In pharma, Ranbaxy is doing very well. So, people can go long on that on all declines. Lupin is doing very well; Dr Reddys Laboratories is doing quite well. These are the two or three stocks that are showing strength even in weak markets."


Share Price Movement During The Last 12 Months
Period Price Latest Price Gain/Loss (Rs.) % Gain/Loss
3-Days 518.90 526.40 7.50 1.45
5-Days 514.05 526.40 12.35 2.40
7-Days 528.65 526.40 -2.25 -0.43
15-Days 498.25 526.40 28.15 5.65
1-Month 474.95 526.40 51.45 10.83
3-Month 434.95 526.40 91.45 21.03
6-Month 397.95 526.40 128.45 32.28
9-Month 414.05 526.40 112.35 27.13
1-Year 380.25 526.40 146.15 38.44


 

Important Links Today:  Leadership Wall    Chat Calendar    The 10 List   
Stock Advice
Sudarshan Sukhani
Technical Analyst
Sudarshan Sukhani
Technical Analyst
 
 
 
WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
©Network 18, 2009. All Rights Reserved